- Why Research
- Our Impact
- Get Involved
- About BCRF
- Research is the reason
- Contact Us
- The Hot Pink Party
You are here
Congratulations to our investigators who were recognized for their contributions
We may not be able to host in-person events, but there are many creative ways to show your support for research
Learn how you can become a Team BCRF runner in this year’s 26.2-mile race
Dr. Martine Piccart talks to us about the power of collaboration in metastatic breast cancer research
Four BCRF investigators received awards of distinction for their advancements in breast cancer research.
Follow these research-backed tips to maintain a healthy lifestyle in 2020 and beyond.
PRESS RELEASE: The AURORA-US Project Reports First Key Findings of Changes Between Primary Tumors and Metastases
Study sheds new light on the differences marking metastatic disease from primary tumor cells and the critical importance for the study of metastatic lesions
PRESS RELEASE: The Breast Cancer Research Foundation Announces the Continued Expansion of the Drug Research Collaborative to Speed the Delivery of New Treatment Options
NEW YORK, NY – December 11, 2019 – The Breast Cancer Research Foundation (BCRF) announced $5 million in funding provided by Eli Lilly and Company to conduct investigator-initiated studies of the CDK4 & 6 inhibitor, Verzenio® (abemaciclib).
Raise money for lifesaving research this holiday season and throughout the new year.
BCRF attended the fifth annual Conquer Cancer Scientific and Career Development Retreat designed to empower early career researchers.